Alphamab Oncology Market Cap

Alphamab Oncology has a market cap or net worth of €1.18 billion as of December 5, 2025. Its market cap has increased by 104.71% in one year.

Market Cap

1.18B

Enterprise Value

1.01B

Revenue

93.42M

Ranking

n/a

PE Ratio

42.66

Stock Price

€1.15

Market Cap Chart

Since December 12, 2019, Alphamab Oncology's market cap has decreased from 1.40B to 1.18B, a decrease of -15.40%. That is a compound annual growth rate of -2.76%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	1.18B	181.22%
Dec 31, 2024	418.85M	-43.55%
Dec 29, 2023	741.95M	-39.08%
Dec 30, 2022	1.22B	-15.24%
Dec 31, 2021	1.44B	-10.46%
Dec 31, 2020	1.60B	11.71%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	248.18B
Siemens Aktiengesellschaft	181.89B
Allianz SE	139.43B
Deutsche Telekom AG	131.24B
Siemens Energy AG	99.98B
Rheinmetall AG	70.18B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	68.26B
Deutsche Bank Aktiengesellschaft	59.33B

Market Cap Rankings